Centogene NV

0.00 (0.00%)
Other Pre-Announcement

Centogene Reports Q4 Results

Published: 03/30/2022 11:44 GMT
Centogene NV (CNTG) - Sees FY Revenue EUR 68 Million to EUR 70 Million.
Total Revenues Derived From Covid-19 Testing is Expected to Be Approximately EUR 18 Million With Expected Phaseout at End of Q1 2022.
Overall Revenues of EUR 42.9 Million Were Recorded in Q4 2021, a 39% Decrease Compared to EUR 70.3 Million in Q4 2020.
Net Loss of EUR 12.3 Million in Q4 2021, Compared to Net Profit of EUR 3.4 Million in Q4 2020.
Q4 Earnings per Share View EUR -0.74, Revenue View EUR 28.4 Million -- Refinitiv Ibes Data (analyst estimates).